Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.
about
Molecular biology of high-grade gliomas: what should the clinician know?IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.G-cimp status prediction of glioblastoma samples using mRNA expression dataAlteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency.Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach.Prognostic and predictive biomarkers in adult and pediatric gliomas: toward personalized treatment.Further understanding of the pathology of glioma: implications for the clinic.An update on the epigenetics of glioblastomas.Methylation-specific multiplex ligation-dependent probe amplification identifies promoter methylation events associated with survival in glioblastoma.Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.Dynamic changes in DNA demethylation in the tree shrew (Tupaia belangeri chinensis) brain during postnatal development and aging.Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas.TET3-mediated DNA oxidation promotes ATR-dependent DNA damage response.Magnetic resonance metabolic imaging of glioma.CpG island methylator phenotype of myelodysplastic syndrome identified through genome-wide profiling of DNA methylation and gene expression.
P2860
Q27009190-6A6B408D-0CA6-4F17-A0CD-6C30EF4CFEB5Q27692015-1F7B2414-2A52-4E7D-BB73-79360F130424Q30576977-48C67E62-F75B-424D-B56A-4E108044925CQ34499746-B9CA9724-8F99-454E-9DD9-BC0C31B8AE36Q38108186-7AD719B5-2A50-4E3D-8CF2-EBA99F4BD042Q38203283-03DE7F5D-1AC3-4963-97D6-832676E826E1Q38844945-05471EE1-BACC-49A3-BCF0-BDC254BC65E7Q38944047-7EE59272-F159-4669-81FB-0730FF13790EQ39247768-1DC4BE54-30A2-4D9B-8BDE-9C5959BF87E3Q42168209-0C3F5B87-3A06-4790-A0FE-0DF39ACF0442Q42213719-899FFC40-CAFD-49F1-B161-E68376B29D0CQ46160223-7DA8023D-122C-42BD-8330-2328700FAB77Q48096192-D80BF019-3D48-4269-9317-4EE274077095Q48716454-84761410-8E8B-4871-B553-DEE0A0C793B6Q54219654-9C60B89C-C0DD-428A-A5DB-B475BE7D2561
P2860
Unraveling the glioma epigenome: from molecular mechanisms to novel biomarkers and therapeutic targets.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Unraveling the glioma epigenom ...... rkers and therapeutic targets.
@en
Unraveling the glioma epigenom ...... rkers and therapeutic targets.
@nl
type
label
Unraveling the glioma epigenom ...... rkers and therapeutic targets.
@en
Unraveling the glioma epigenom ...... rkers and therapeutic targets.
@nl
prefLabel
Unraveling the glioma epigenom ...... rkers and therapeutic targets.
@en
Unraveling the glioma epigenom ...... rkers and therapeutic targets.
@nl
P2860
P1433
P1476
Unraveling the glioma epigenom ...... rkers and therapeutic targets.
@en
P2093
Bastian Malzkorn
Markus J Riemenschneider
P2860
P304
P356
10.1111/J.1750-3639.2011.00536.X
P577
2011-11-01T00:00:00Z